glp-1 drug GLP1 Use For Weight Loss Has Soared Costing Billions Poll: 1 in 8 Adults
Description
doi: 10.1016/j.jhep.2023.07.033
But for now, we have new options that are safe, appear to reduce complications, and are very effective
However, most of these studies used standard doses approved for diabetes or obesity, and dedicated trials examining low-dose GLP-1 specifically for inflammatory conditions are lacking
Bleeding Risk The most common adverse reactions when combining GLP-1R agonists with traditional antithrombotic drugs such as aspirin, clopidogrel, or direct oral anticoagulants (DOACs) include gastrointestinal symptoms of nausea, vomiting, abdominal cramping, and increased bleeding risks
